Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis

BACKGROUND: It is unclear whether continuing anti-fibrotic therapy until the time of lung transplant increases the risk of complications in patients with idiopathic pulmonary fibrosis. OBJECTIVES: To investigate whether the time between discontinuation of anti-fibrotic therapy and lung transplant in...

Descripción completa

Detalles Bibliográficos
Autores principales: Astor, Todd L., Goldberg, Hilary J., Snyder, Laurie D., Courtwright, Andrew, Hachem, Ramsey, Pena, Tahuanty, Zaffiri, Lorenzo, Criner, Gerard J., Budev, Marie M., Thaniyavarn, Tany, Leonard, Thomas B., Bender, Shaun, Barakat, Aliaa, Breeze, Janis L., LaCamera, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126649/
https://www.ncbi.nlm.nih.gov/pubmed/37073794
http://dx.doi.org/10.1177/17534666231165912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126649/
https://www.ncbi.nlm.nih.gov/pubmed/37073794
http://dx.doi.org/10.1177/17534666231165912

Ejemplares similares